Investor Suit Over Alleged Parkinson’s Disease Drug Misstatements Dismissed

Mealey's (January 5, 2022, 2:12 PM EST) -- SAN DIEGO — Ruling that the lead plaintiff in a securities class action against a drug company and several of its current and former senior executives has three times failed to...
To view the full article, register now.